Developmental Research Program
Developmental Research Program
批准号:
9071068
负责人:
James Brugarolas
金额:
$16.85万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2021-07-31
关键词:
Antisense OligonucleotidesAreaAugmented RealityAwardBudgetsCancer CenterCancer PatientCancer Research ProjectClinicalCollaborationsDevelopmentDoseEligibility DeterminationEnsureEvaluationFosteringFundingFunding AgencyGoalsGrantHumanHypertensionIL2 geneImmuneInternationalLeadershipLettersMedical centerMentorsMinorityMissionMolecularMusNephrectomyOperative Surgical ProceduresOutcomeParticipantPatientsPeer ReviewPhase II Clinical TrialsPhysiciansPreparationProgram Research Project GrantsPublicationsQualifyingRadiationRaptorsRecruitment ActivityRenal carcinomaRequest for ApplicationsResearchResearch PersonnelResourcesRoboticsScientific Advances and AccomplishmentsScientistSeedsSelection CriteriaSignal TransductionSourceTexasTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthUniversitiesWomanWorkanticancer researchbiomarker identificationdesignhigh riskimproved outcomeinnovationinterestmeetingsmultidisciplinaryprogramsresearch studyresponsesuccesssynergismtooltranscription factortrendtumor
中文摘要
项目总结
英文摘要
Project Summary
The Developmental Research Program (DRP) of the UTSW kidney cancer SPORE grant provides seed
funding for promising translational projects that can significantly impact kidney cancer research. The DRP will
fund pilot and/or high-impact/high-risk projects using innovative approaches, with the potential to generate
groundbreaking discoveries, and a focus on translation. The DRP is led by Dr. Brugarolas, the SPORE
Director, and Project 4 Co-Leader, Dr. Mendell. Their research is characterized by innovation and translation,
two attributes sought in DRP projects. DRP proposals will be solicited via the Administrative Core; they will be
prescreened for eligibility, suitability, and relevance by the DRP leadership; reviewed by two internal and one
external expert; and approved for funding by the SPORE Executive Committee. As part of our mission to
increase diversity, mechanisms are in place to recruit women and minorities. In addition to the $100,000/yr
designated for the DRP through the SPORE grant, UTSW, via the Simmons Cancer Center, is committing an
additional $100,000/yr for a total of $200,000 to fund DRP projects annually. The DRP will award 2-4 projects
per year (a total of 15-20 projects over 5 years). Criteria for selection include: significance, innovation,
approach, investigator qualifications, and translational potential (or synergism with existing projects). Priority
will be given to projects with the potential to become full SPORE projects. The specific aims of the DRP are to:
1) Serve as a mechanism to provide seed funding for promising projects. 2) Identify and recruit a pool of
promising scientists and physician-scientists. 3) Facilitate the development and progress of the DRP projects
and the transition of successful projects into competitive applications for peer-reviewed funding. 4) Support
SPORE DRP awardees to ensure that scientific advances are translated into improved outcomes for kidney
cancer patients. DRP awardees will have full use of SPORE Core resources, will benefit from the expertise and
leadership of the SPORE investigators (who may serve as mentors), and will be an integral part of SPORE
meetings, where they will regularly present their work. Metrics of success for DRP recipients include:
invitations to present at national and international scientific meetings; successful competition for independent
NIH grant support (in particular R01 grants); publication of original research studies in the supported area; and,
institutional recognition by promotion through the academic ranks. DRP projects that make significant progress
towards their translational goals have the potential to be promoted to full SPORE projects. In response to a
request for applications, 9 letters of intent were received including 4 that are showcased. A rich and diverse
pipeline of research interests/expertise pertinent to kidney cancers at UTSW populates a dynamic DRP,
expanding the breadth and depth of the SPORE/Kidney Cancer Program research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
-
批准号:10443836
-
项目类别:
-
资助金额:$22.54万
-
财政年份:2021
-
负责人:James Brugarolas
-
依托单位:
Dissecting the mechanism of cabozantinib anti-tumor effect in renal cancer
-
批准号:10289979
-
项目类别:
-
资助金额:$19.16万
-
财政年份:2021
-
负责人:James Brugarolas
-
依托单位:
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
-
批准号:9071063
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
-
批准号:9752982
-
项目类别:
-
资助金额:$213.8万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Developmental Research Program
-
批准号:10708855
-
项目类别:
-
资助金额:$20.66万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
University of Texas Southwestern Medical Center SPORE in Kidney Cancer
-
批准号:10706530
-
项目类别:
-
资助金额:$217.34万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Project 1: Targeting HIF2 in Renal Cell Carcinoma
-
批准号:10708828
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Core A: Administrative Core
-
批准号:10708829
-
项目类别:
-
资助金额:$14.59万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Core A: Administrative Core
-
批准号:9071064
-
项目类别:
-
资助金额:$16.33万
-
财政年份:2016
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:9008030
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:8632102
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:8777950
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Evaluation of the BAP1 tumor suppressor gene in renal cell carcinoma
-
批准号:9185277
-
项目类别:
-
资助金额:$32.99万
-
财政年份:2013
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:8118778
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:7581865
-
项目类别:
-
资助金额:$31.93万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:7894594
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:7690291
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
Regulation of the mTOR Pathway by Hypoxia and the REDD1 Protein
-
批准号:8304398
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2008
-
负责人:James Brugarolas
-
依托单位:
VEGF regulation by the TSC2 tumor suppressor
-
批准号:7068600
-
项目类别:
-
资助金额:$15.1万
-
财政年份:2005
-
负责人:James Brugarolas
-
依托单位:
VEGF regulation by the TSC2 tumor suppressor
-
批准号:7421034
-
项目类别:
-
资助金额:$17.3万
-
财政年份:2005
-
负责人:James Brugarolas
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: